AstraZeneca PLC is 188.8x more valuable than ANAPTYSBIO, INC by market capitalization ($286.27 B vs $1.52 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ANAB | AZN |
|---|---|---|
| Market cap | $1.52 B | $286.27 B |
| US-listed rank | #2310 | #45 |
| Revenue (latest FY) | $234.60M | - |
| Net income (latest FY) | -$13.23M | - |
| Net margin | -5.6% | - |
| SEC filings | 681 | 1,004 |
AstraZeneca PLC is 188.8x more valuable than ANAPTYSBIO, INC by market capitalization ($286.27 B vs $1.52 B).
Full pages: ANAPTYSBIO, INC and AstraZeneca PLC, or browse the full rankings.